Fuda Cancer Hospital - Malaysia

Fuda Cancer Hospital - Malaysia Fuda is committed to providing cancer patients around the world with the best medical care. There are totally 400 beds, of which 45 are VIP wards .
(1)

Located in Tianhe District (North Campus) and Haizhu District (South Campus) of Guangzhou City, Fuda Cancer Hospital is under the jurisdiction of Health supervision bureau of Guangdong Province, a bureau that mostly regulates government founded hospitals. Fuda is an affiliated hospital to Jinan University and is the Translational Medicine Center of Guangzhou Institute of Biomedicine and Health of Chinese Academy of Sciences. Fuda operates under the international standards, and was selected as the National Key Clinical Speciality hospital (Oncology) in 2010. Fuda has several highly efficient and professional teams: cryosurgical ablation team, micro-vascular intervention team, immunotherapy team, surgical teams for head-neck, chest and a team for hepato-biliary cancer. The Joint Commission International (JCI), one of the most widely recognized hospital evaluation system, accredited Fuda Cancer Hospital in 2013. In Fuda, we value technology, integrity and humanity. Life is what we hold dear here. Fuda has been providing patients around the world with high-tech, world-class medical services. With all the miracles and success made in the past decade, Fuda is striving to reach the ultimate goal to become a hospital that is specialized in most novel cancer treatment, equipped with advanced medical instrument and focuses on cutting-edge oncological science. In the past decade, Fuda has been using latest cancer-treating technologies to treat patients who were in early or advanced stage of cancer. Fuda's treatment has helped patients by significantly prolonging patient’s survival time and improving life quality. Fuda has developed a unique “3C+P” treatment model, which is, cryosurgical ablation (CSA), CANCER MICRO-VASCULAR INTERVENTION (CMI), COMBINED IMMUNOTHERAPY FOR CANCER (CIC), AND PERSONALIZED TREATMENTS (P). So far, Fuda has had more than 10,000 cases of cryosurgical ablation, which ranks No.1 in the world in terms of quantity as well as the types of cancer treated. Fuda has attracted cancer patients from more than 70 countries around the world, 70 percent of patients from foreign countries in South-East Asia, the Middle East, Oceanic, Europe and North America. Fuda has received various awards in China and abroad for outstanding achievements in treating cancer and been highly praised by patients around the world.

【患者故事】【岛国-口咽鳞状细胞癌-动脉灌注化疗】咽部不适竟是口咽癌?外籍男子拒绝手术,跨国追寻“中国方案”从小小的喉咙不适,到后来张不开嘴、说不出话、刷不了牙,连喝水都变得困难;听力越来越差,头时常作痛,甚至脸型也慢慢变了样……这一切,竟...
12/02/2026

【患者故事】【岛国-口咽鳞状细胞癌-动脉灌注化疗】
咽部不适竟是口咽癌?外籍男子拒绝手术,跨国追寻“中国方案”
从小小的喉咙不适,到后来张不开嘴、说不出话、刷不了牙,连喝水都变得困难;听力越来越差,头时常作痛,甚至脸型也慢慢变了样……这一切,竟然开始于一次“不太起眼”的咽部难受。
罗先生(化名)出生于遥远的岛国。2024年年底,他突然觉得右边喉咙有些不舒服,起初并没在意。谁知不适感越来越重,到了2025年3月,他发现口咽部有个肿块,却依然拖着没去医院。
直到两个月后,他的脖子两侧先后鼓起了肿块,右耳听力也明显下降,他才真正警觉起来,在菲律宾一家医院做了检查。然而,确诊消息来得沉重——口咽鳞状细胞癌,那时已是2025年10月。此时的罗先生,右侧鼻子不通气,听力模糊,吞咽困难,脸颊和喉咙胀痛,口咽部肿物还偶尔渗血……日常每一刻都成了煎熬。
健康小知识
口咽,这个隐藏在口腔后方的“神秘通道”,前方经咽口与口腔相通。它像一座繁忙的交通枢纽,负责呼吸、吞咽和发声。而当癌细胞在这里“安家落户”,最初的表现往往可能是持续不愈的咽喉痛、吞咽异物感,或是声音的改变。

△图片来源于网络
因此,若喉咙出现这些异常,请及时就医:
持续的口咽部异物感,尤其吞咽时加重(不同于咽炎进食时可能缓解);
持续的口咽部疼痛,影响生活;
口腔溃疡久治不愈,或口腔内有不明原因出血;
颈部出现无痛性肿块(淋巴结肿大),抗炎治疗无效;
张口困难、呼吸困难(晚期症状)。
一旦出现上述可疑症状,尤其是持续不缓解时,请及时就医。
当地医生建议手术,但手术创伤面积大,罗先生拒绝了。在他心里,手术是最后的选择,“一定还有更先进、更温和的办法。”通过社交媒体,他了解到中国的广州复大肿瘤医院,以及那里特色的微创治疗技术。抱着试一试的心情,他通过复大在菲律宾的服务中心联系上医生,并进行了线上咨询。当听到自己还有多种治疗选择时,他立刻做了决定:飞往中国。
在复大,详细检查显示:肿瘤已侵犯到鼻咽、软腭及右侧肌肉,且伴发出血风险。医疗团队没有采用传统大开刀的方式,而是为他量身制定了一套“组合方案”:通过动脉灌注化疗精准攻击肿瘤,并用介入栓塞术封堵血管、降低出血可能;同时配合静脉滴注PD-1抑制剂,重新激活免疫系统识别和杀伤肿瘤细胞的能力,去对抗癌细胞。
治疗带来的变化,连罗先生自己都感到惊喜。没过多久,他右边鼻子通气了,听力好转了,脖子上的肿块也明显缩小;吞咽不再困难,吃饭、睡觉都踏实了许多。虽然声音还有些沙哑,但他的笑声爽朗极了。

△两个疗程后的CT对比图,口咽肿物、颈部肿块缩小
他说,自己十几年前曾到过中国,但这次是以患者的身份初次来到广州,起初紧张得血压一直升高。可这里的专业医术和温暖护理,很快让他放下了心来。这次经历,也让他深深喜欢上了中国。他说,接下来想好好学习中文,体验中国的风土人情,好好感受这个国家的魅力。
目前,罗先生的治疗还在继续。我们祝福他,一步步走向康复,重新拥抱有声有色、自由自在的生活。

點擊了解更多患者故事
>>> https://hongkong.fudahospital.com/

您可以通過以下方式聯絡我們:
☎️電話: +60 19 996 4656
🌟Whatsapp: +60 19 996 4656
🌍網站: https://hongkong.fudahospital.com

[Patient Story][Antigua and Barbuda – Oropharyngeal Squamous Cell Carcinoma – Arterial Infusion Chemotherapy]Simple Sore...
12/02/2026

[Patient Story]
[Antigua and Barbuda – Oropharyngeal Squamous Cell Carcinoma – Arterial Infusion Chemotherapy]
Simple Sore Throat Turned Out to Be Oropharyngeal Cancer:Foreign Patient Refuses Surgery and Travels Across Borders in Search of a “China Solution”
What began as a mild discomfort in the throat gradually worsened—until Robert (pseudonym) could no longer open his mouth properly, speak clearly, or even brush his teeth. Drinking water became difficult. His hearing deteriorated, headaches became frequent, and even the shape of his face slowly changed.
All of this started from what seemed like an “insignificant” throat discomfort.
Robert was born in Antigua and Barbuda, a small island nation in the Caribbean. Toward the end of 2024, he began to feel discomfort on the right side of his throat. At first, he paid little attention. However, the symptoms continued to worsen. By March 2025, he noticed a mass in his oropharynx, yet still delayed seeking medical care.
Two months later, lumps appeared on both sides of his neck, and hearing loss in his right ear became obvious. Only then did he realize the seriousness of the situation and underwent examinations at a hospital in the Philippines.
The diagnosis was devastating: oropharyngeal squamous cell carcinoma. By October 2025, the disease had already progressed.
At that time, Robert was suffering from nasal obstruction on the right side, hearing impairment, difficulty swallowing, swelling and pain in his cheek and throat, and occasional bleeding from the oropharyngeal mass. Everyday life had become a constant ordeal.
Health Insight
The oropharynx, hidden behind the oral cavity, acts as a vital crossroads for breathing, swallowing, and speech. When cancer develops in this area, early symptoms are often subtle and easily overlooked—such as persistent sore throat, a sensation of a foreign body when swallowing, or changes in voice.

Image source: Internet
Seek medical attention promptly if you experience:
Persistent foreign-body sensation in the oropharynx, especially worsening during swallowing (unlike pharyngitis, which may improve while eating);
Continuous throat pain affecting daily life;
Oral ulcers that do not heal, or unexplained bleeding in the mouth;
Painless neck lumps (enlarged lymph nodes) unresponsive to anti-inflammatory treatment;
Difficulty opening the mouth or breathing (late-stage symptoms).
If any of these symptoms persist, timely medical evaluation is strongly recommended.
Local doctors advised radical surgery, but the potential extensive trauma led Robert to refuse it. In his mind, surgery was a last resort.
“There must be a more advanced and gentler option,” he believed.
Through social media, Robert learned about Guangzhou Fuda Cancer Hospital in China and its specialized minimally invasive treatment approaches. With a hopeful mindset, he contacted Fuda’s service center in the Philippines and completed an online consultation. When he learned that multiple treatment options were still available to him, he made a decisive choice—to travel to China.
At Fuda, comprehensive examinations revealed that the tumor had invaded the nasopharynx, soft palate, and right-sided muscles, with a high risk of bleeding. Instead of traditional open surgery, the medical team designed a personalized combination treatment plan:
Arterial infusion chemotherapy to deliver drugs directly to the tumor with high precision;
Interventional embolization to block blood vessels and reduce bleeding risk;
Combined with intravenous PD-1 inhibitor immunotherapy, reactivating the immune system to recognize and attack cancer cells.
The results exceeded Robert’s expectations.
Before long, his right nasal passage became clear, his hearing improved, and the neck masses visibly shrank. Swallowing was no longer difficult, and he could finally eat and sleep comfortably again. Although his voice remained slightly hoarse, his laughter was loud and genuine.

CT comparison after two treatment cycles showing reduction of oropharyngeal tumor and cervical masses
Robert shared that he had visited China more than a decade ago, but this was his first time coming to Guangzhou as a patient. At the beginning, anxiety kept his blood pressure elevated. Yet the hospital’s professional expertise and warm, attentive care quickly put him at ease.
This experience made him truly fall in love with China. He said that he hopes to seriously learn Chinese in the future, explore the country’s culture, and fully experience its unique charm.
Robert’s treatment is still ongoing. We sincerely wish him steady progress toward recovery—and a return to a life filled with sound, freedom, and color.

Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 996 4656
🌟 WhatsApp: +60 19 996 4656
🌍 Website: https://en.fudahospital.com/

【Fuda News】【International Conference – Society of Interventional Oncology (SIO) Annual Meeting, USA】China’s “Cryoablatio...
12/02/2026

【Fuda News】【International Conference – Society of Interventional Oncology (SIO) Annual Meeting, USA】
China’s “Cryoablation + Immunotherapy + Chemotherapy” Approach Presented at SIO 2026
From February 4 to 8, 2026, the Annual Meeting of the Society of Interventional Oncology (SIO) was grandly held in Savannah, USA. Formerly known as the World Conference on Interventional Oncology (WCIO), SIO has been dedicated since its establishment in January 2017 to building, nurturing, and advancing the cutting-edge field of interventional oncology, and has become one of the most influential international platforms for academic exchange in this discipline.
This year’s meeting brought together leading experts, scholars, and clinicians from around the world in interventional oncology and related fields. Through cutting-edge keynote sessions, panel discussions, invited oral presentations, and selected abstract presentations, participants explored multidisciplinary topics spanning radiology, medical oncology, surgery, interventional therapy, hepatology, and radiation oncology, with a shared focus on optimizing existing treatment paradigms and integrating emerging technologies.

Notably, in the Scientific Oral Presentation session, there was only one presentation delivered by a Chinese hospital. This presentation was given by Director Liu Shupeng, a medical expert from Guangzhou Fuda Cancer Hospital, and focused on comprehensive treatment strategies for advanced lung cancer. It highlighted China’s clinical practice and research progress in interventional oncology, contributing Chinese insight and experience to the global development of the field.

The presentation addressed a key challenge in current lung cancer treatment: despite the widespread use of targeted therapies and chemotherapy, some patients still develop drug resistance in the mid-to-late stages of treatment. Director Liu systematically introduced a combined regimen of cryoablation + PD-1 inhibitors + chemotherapy. In this approach, cryoablation induces immunogenic cell death, PD-1 inhibitors restore T-cell function, and chemotherapy enhances tumor antigen exposure. Through their synergistic effects, this integrated strategy offers new therapeutic possibilities for patients with advanced non-small cell lung cancer. This innovative and practice-oriented Chinese approach attracted widespread attention and lively discussion among international peers at the conference.



Taking this opportunity, Guangzhou Fuda Cancer Hospital will continue to deepen its exchanges and collaborations with the international medical community, actively contributing China’s clinical expertise and research perspectives. To date, the hospital has provided medical services to patients from more than 120 countries and regions worldwide. Looking ahead, it will continue to promote the global development of interventional oncology, bringing new hope to more cancer patients around the world.

Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 996 4656
🌟 WhatsApp: +60 19 996 4656
🌍 Website: https://en.fudahospital.com/

【复大新闻】【国际会议-美国介入肿瘤学会年会(SIO)】来自中国的“冷冻+免疫+化疗”方案,亮相SIO2026年会2026年2月4日至8日,美国介入肿瘤学会年会(SIO)在萨凡纳隆重举行。该年会前身为世界肿瘤介入大会(WCIO),自2017...
12/02/2026

【复大新闻】【国际会议-美国介入肿瘤学会年会(SIO)】
来自中国的“冷冻+免疫+化疗”方案,亮相SIO2026年会
2026年2月4日至8日,美国介入肿瘤学会年会(SIO)在萨凡纳隆重举行。该年会前身为世界肿瘤介入大会(WCIO),自2017年1月成立以来,始终致力于构建、培育并推动介入肿瘤学这一前沿领域的发展,已成为该领域最具影响力的国际交流平台之一。
本届年会汇聚了来自全球肿瘤介入治疗及相关领域的顶尖专家、学者与临床医生。通过前沿专题报告、小组讨论、特邀论文发言及精选摘要展示等形式,围绕放射学、肿瘤内科学、外科学、介入治疗学、肝病学与放射肿瘤学等多学科交叉议题,共同探索现有治疗模式的优化与新兴技术的融合路径。

值得一提的是,本次大会的口头科学报告环节中,来自中国医院的发言仅有一席,由广州复大肿瘤医院医疗专家刘树鹏主任完成,其内容聚焦进展期肺癌的综合治疗,展现了我国在肿瘤介入治疗领域的临床实践与研究进展,为全球介入肿瘤学的发展贡献了中国智慧与经验。

该报告聚焦当前肺癌临床治疗的难点——即在靶向及化疗药物广泛应用后,仍有部分患者在治疗中后期出现耐药现象。刘树鹏主任系统介绍了“冷冻消融+PD-1抑制剂+化疗”综合疗法,该方案通过冷冻消融(诱导免疫原性细胞死亡)、PD-1抑制剂(恢复T细胞功能)、化疗(增强肿瘤抗原暴露),三者协同作用,为晚期非小细胞肺癌患者提供了新的治疗可能。这一兼具创新性与实践意义的中国方案,在会场上引发了国际同行的广泛关注与热烈讨论。


广州复大肿瘤医院以此为契机,将继续深化与国际医学界的交流合作,积极贡献来自中国的临床智慧与科研声音。目前,医院已为来自全球120多个国家和地区的患者提供诊疗服务,未来将持续推动介入肿瘤学的全球化发展,为世界范围内更多肿瘤患者带来生命新希望。

點擊了解更多患者故事
>>> https://hongkong.fudahospital.com/

您可以通過以下方式聯絡我們:
☎️電話: +60 19 996 4656
🌟Whatsapp: +60 19 996 4656
🌍網站: https://hongkong.fudahospital.com

10/02/2026

【Pancreatic Cancer】【Cryoablation Nanoknife】
>>>New Option for Pancreatic Cancer> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 996 4656
🌟 WhatsApp: +60 19 996 4656
🌍 Website: https://en.fudahospital.com/

05/02/2026

【Minimally Invasive Treatment】【Lung nodule-Cryoablation + Simultaneous biopsy】
>>>Companion Puncture Technique: A Breakthrough in Biopsy of Small Lung Nodules> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 996 4656
🌟 WhatsApp: +60 19 996 4656
🌍 Website: https://en.fudahospital.com/

【患者故事】【中国-肺腺癌-冷冻】三人罹癌,一个鞠躬:河南家庭在复大点亮希望之灯“我一定要给院长和主任鞠个躬,是你们救了我们全家!”丁大叔的爱人将锦旗递到牛立志院长与李红梅主任手中,深深鞠了次躬。她眼眶湿润,声音哽咽,一遍遍说着:“谢谢,真...
05/02/2026

【患者故事】【中国-肺腺癌-冷冻】
三人罹癌,一个鞠躬:河南家庭在复大点亮希望之灯
“我一定要给院长和主任鞠个躬,是你们救了我们全家!”丁大叔的爱人将锦旗递到牛立志院长与李红梅主任手中,深深鞠了次躬。她眼眶湿润,声音哽咽,一遍遍说着:“谢谢,真的谢谢你们……”

时间回到2025年7月。七十多岁的丁大叔来自河南,起初只是咳嗽、咳痰,以为是慢性咽炎或小感冒,便在社区医院打针吃药。可症状迟迟不见好转,他去当地医院做了胸部CT,结果医生面色凝重地告诉他:“肺上有问题。”
一家人辗转多家医院,最终才弄清肺上的问题:双肺多发结节,左肺上叶有一个2.1cm×1.7cm的实性结节,边缘不整,倾向恶性;右肺还有多个磨玻璃结节,考虑为早期肺癌,最大的约2.6cm×2.1cm×2.4cm,位于右肺上叶后段胸膜下。
带着厚厚的检查报告,他们赶往北京。排队、等待,足足花了十几天,得到的却是专家沉重的分析:心脏病、脊柱病,还做过两次支架手术,年纪大、双肺都有问题,如果手术,一边切了,另一边很可能无法再动刀,术后恢复更是未知数……每一句话,都像锤子砸在一家人心上。希望,似乎一点点熄灭了。
“要不,去广州复大肿瘤医院试试?”弟媳的一个电话,让陷入黑暗的丁家看到一束光。原来,丁大叔的侄女2022年确诊乳腺癌晚期,曾被断言仅剩三个月生命。她熬过一次次化疗,经历一次次耐药,却仍难阻癌症进展。2024年底来到复大时,她胸口已溃烂如苹果大小,日夜剧痛。但经过六次介入治疗和ADC药物治疗,溃烂面缩小到指甲盖大小。她说:“以前只知道手术、放化疗,来了复大才知道,还有不一样的路。”同村一位患过乳腺癌的长辈也对复大充满肯定。
带着这份信念,2025年8月,丁大叔一家来到复大医疗六科。李红梅主任带领团队仔细评估:老人双肺肺气肿、多发结节,还装着心脏支架,需长期服药。如果传统手术,风险极高,肺功能可能严重受损。经过反复讨论,团队决定采用更稳妥的策略——先对左肺高风险结节进行活检并同步冷冻消融,之后再处理右肺的多发磨玻璃结节。
考虑到丁大叔的心脏药不能停太久,李红梅主任还特意协调,为他加急安排了手术。手术很顺利,术后病理显示是(左肺上叶)低分化腺癌。丁大叔回忆:“下午3点进手术室,4点左右就出来了,穿刺只有一点可以忍受的疼。”更让他和家人欣慰的是,术后很快就能下床,日常生活几乎没受影响。回家后,亲戚朋友见到他都惊讶不已:“这哪像病人?精神头比好多人都足!”毕竟,在此之前,他们认为丁大叔能不能走回来都不一定。
两个月后,丁大叔再次接受冷冻消融术,一次处理了右肺三个结节。和第一次一样,恢复很快,生活如常。之后,他又配合做了几次介入治疗。“医生说,这样做是为了清除可能藏着的、肉眼看不见的癌细胞,更保险。”如今,丁大叔仍在规律治疗中,说话中气十足。他把每次治疗都认真记在本子上,也把复大医护的细心与温暖刻在心里。
曾经,癌症对他们全家来说,就像一张绝望的判决书。但在这里,他们重新拾起了希望。

“都是病友之间口口相传,说这家医院真的不一样。”丁大叔感慨,“这里能治的,医生会想尽办法;不能治的,也会坦诚相告,绝不拖延。”不久前,丁大叔的弟媳也查出肠癌,同样选择来到医疗六科治疗。她说:“在复大,我心里踏实。”
这次送来锦旗,丁大叔的爱人红着眼圈说,她已经和牛立志院长合了三次影,每一次心情都不同——从忐忑到信任,从感激到充满希望。一张照片,记录一段路;一面锦旗,承载一家情。

生命的路,有时走着走着,仿佛入了夜。但总有一些人、一些地方,愿意为你点亮一盏灯,陪你在风雨中走一段,直到天亮。对丁大叔一家来说,复大就是这样一束光——照进的不仅是病房,更是那颗几乎放弃的心。而这束光,还在继续温暖着更多像他们一样,渴望重生的人。

點擊了解更多患者故事
>>> https://hongkong.fudahospital.com/

您可以通過以下方式聯絡我們:
☎️電話: +60 19 996 4656
🌟Whatsapp: +60 19 996 4656
🌍網站: https://hongkong.fudahospital.com

【Patient Story】【China · Lung adenocarcinoma · Cryoablation】Three Diagnoses, One Deep Bow: A Henan Family Finds Hope at F...
05/02/2026

【Patient Story】【China · Lung adenocarcinoma · Cryoablation】
Three Diagnoses, One Deep Bow: A Henan Family Finds Hope at Fuda
“I must bow to the hospital president and the department director—you saved our whole family.”
As she presented a banner of gratitude to President Niu Lizhi and Director Li Hongmei, Uncle Ding’s wife bowed deeply. Her eyes brimmed with tears, her voice trembling as she repeated again and again, “Thank you—truly, thank you…”

The story goes back to July 2025. Uncle Ding, in his seventies and from Henan Province, initially had only a cough with phlegm. Assuming it was chronic pharyngitis or a minor cold, he received injections and medication at a community clinic. But the symptoms lingered. A chest CT at a local hospital brought grave news from the doctor: “There’s a problem in the lungs.”
After visits to multiple hospitals, the diagnosis became clear: multiple nodules in both lungs. In the left upper lobe, there was a 2.1 × 1.7 cm solid nodule with irregular margins, suspicious for malignancy. The right lung harbored several ground-glass nodules, considered early-stage lung cancer; the largest measured 2.6 × 2.1 × 2.4 cm, located subpleurally in the posterior segment of the right upper lobe.
With a thick stack of reports, the family traveled to Beijing. Days of queuing and waiting led to a sobering assessment from specialists: heart disease, spinal problems, two prior stent procedures, advanced age, and lesions in both lungs. Surgery would be extremely risky—if one side were resected, the other might not be operable later, and postoperative recovery was uncertain. Each sentence felt like a hammer blow. Hope seemed to fade.
“Why not try Guangzhou Fuda Cancer Hospital?” A call from a sister-in-law pierced the darkness with a beam of light. In 2022, Uncle Ding’s niece had been diagnosed with advanced breast cancer and was told she had only three months to live. She endured rounds of chemotherapy and drug resistance as the disease progressed. When she arrived at Fuda in late 2024, a chest lesion had ulcerated to the size of an apple, causing relentless pain. After six interventional treatments combined with ADC therapy, the ulcer shrank to the size of a fingernail. “I used to think there were only surgery, chemo, and radiotherapy,” she said. “I didn’t know there were other paths until I came to Fuda.” An elder from the same village who had also had breast cancer spoke highly of Fuda as well.
Holding onto this belief, in August 2025 Uncle Ding’s family came to Medical Department Six at Fuda. Director Li Hongmei and her team conducted a thorough evaluation: bilateral emphysema, multiple lung nodules, cardiac stents requiring long-term medication. Conventional surgery carried extremely high risk and could severely impair lung function. After repeated discussions, the team chose a safer strategy—biopsy with simultaneous cryoablation of the high-risk left lung nodule first, followed by treatment of the multiple ground-glass nodules in the right lung.
Because Uncle Ding could not stop his cardiac medications for long, Director Li personally coordinated an expedited procedure. The surgery went smoothly. Postoperative pathology confirmed poorly differentiated adenocarcinoma of the left upper lobe. Uncle Ding recalled, “I went into the OR around 3 p.m. and came out by about 4. The puncture pain was minimal and tolerable.” What reassured the family most was his rapid recovery—he was soon able to get out of bed, with little impact on daily life. Back home, relatives and friends were amazed: “He doesn’t look like a patient at all—his energy is better than many healthy people!” Before this, they weren’t even sure he’d be able to walk back.
Two months later, Uncle Ding underwent another cryoablation, treating three nodules in the right lung in a single session. Recovery was again swift, life quickly returning to normal. He then completed several additional interventional treatments. “The doctors said this helps eliminate any hidden cancer cells that can’t be seen with the naked eye—making it safer,” he explained. Today, Uncle Ding continues regular treatment, speaking with vigor. He carefully records each session in a notebook and keeps the team’s attentiveness and warmth close to his heart.
Once, cancer felt like a verdict of despair for the entire family. Here, they found hope again.

“Patients keep recommending this hospital by word of mouth—it really is different,” Uncle Ding reflected. “If it can be treated, the doctors will do everything possible. If it can’t, they’ll tell you honestly and never delay.” Recently, his sister-in-law was diagnosed with colon cancer and also chose Medical Department Six. “At Fuda, I feel at ease,” she said.
When they presented the banner this time, Uncle Ding’s wife said with reddened eyes that she had taken photos with President Niu three times—each capturing a different emotion: from anxiety to trust, from gratitude to hope. A photograph records a journey; a banner carries a family’s heartfelt thanks.

Life’s path can sometimes feel like night falling as you walk. But there are people—and places—willing to light a lamp, to walk with you through wind and rain until dawn. For Uncle Ding’s family, Fuda is that light—illuminating not only the hospital room, but hearts that had nearly given up. And that light continues to warm many others who, like them, long for a new beginning.

Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 996 4656
🌟 WhatsApp: +60 19 996 4656
🌍 Website: https://en.fudahospital.com/

28/01/2026

Address

Level 27-05, Tower B, Pavilion Embassy, 200 Jalan Ampang
Kuala Lumpur
50450

Telephone

+60199964656

Website

https://english.fudaguangzhou.com/

Alerts

Be the first to know and let us send you an email when Fuda Cancer Hospital - Malaysia posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Fuda Cancer Hospital - Malaysia:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category